VAERS reports by lot

GSK Flu lot B9G34: VAERS reports

24 VAERS reports list lot B9G34 as a GSK Flu vaccine, received between 2016-10-07 and 2017-07-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
38%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Musculoskeletal1518%
Injection-site / Local reaction1316%
Neurological1214%
Dermatological (non-injection-site)1113%
Gastrointestinal810%
General / Systemic (non-local)810%
Allergic / Anaphylactic78%
Cardiac / Cardiovascular56%
Respiratory34%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California7
Missouri3
Illinois3
Wyoming1
Arkansas1
Iowa1
Nebraska1
Minnesota1
Utah1
Kansas1
Georgia1
Mississippi1

Reports by month received

2016-1013
2016-115
2017-031
2017-042
2017-052
2017-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.